Our model describes signaling and gene regulatory processes that are important for B-cell development and therefore already contain a number of components that are known oncogenes or tumor suppressors in DLBCL, such as BCL6 or BCL2. Here, BCL2 is linked to diffuse large B-cell lymphoma.